Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 739

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

EMT and tumor metastasis

Open access
Heerboth, Sarah, Housman, Genevieve, Leary, Meghan, Longacre, Mckenna, Byler, Shannon, Lapinska, Karolina, Willbanks, Amber, Sarkar, Sibaji·2015·Clinical and Translational Medicine

Abstract

EMT and MET comprise the processes by which cells transit between epithelial and mesenchymal states, and they play integral roles in both normal development and cancer metastasis. This article reviews these processes and the molecular pathways that contribute to them. First, we compare embryogenesis and development with cancer metastasis. We then discuss the signaling pathways and the differential expression and down‐regulation of receptors in both tumor cells and stromal cells, which play a role in EMT and metastasis. We further delve into the clinical implications of EMT and MET in several types of tumors, and lastly, we discuss the role of epigenetic events that regulate EMT/MET processes. We hypothesize that reversible epigenetic events regulate both EMT and MET, and thus, also regulate the development of different types of metastatic cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40169-015-0048-3

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 135 references

Research works printed but not linked: 13

  1. Rosenmayr‐Templeton L, 2010, Industry update: The latest developments in therapeutic delivery, Ther Deliv., 1, 369, 10.4155/tde.10.51 · doi:10.4155/tde.10.51
  2. 10.1016/j.urolonc.2008.09.041 · doi:10.1016/j.urolonc.2008.09.041
  3. Zhang K, 2011, Activation of NF‐kB upregulates Snail and consequent repression of E‐cadherin in cholangiocarcinoma cell invasion, Hepatogastroenterology., 58, 1
  4. Park S, 2007, The dual effects of interleukin‐18 in tumor progression, Cell Mol Immunol., 4, 329
  5. 10.1002/(SICI)1097-0142(19971015)80:8 <1529::AID-CNCR2>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19971015)80:8
  6. 10.1158/1078-0432.CCR-07-1042 · doi:10.1158/1078-0432.ccr-07-1042
  7. 10.4161/onci.27220 · doi:10.4161/onci.27220
  8. Clintron J, 1996, Colorectal cancer and peritoneal carcinomatosis, Semin Surg Oncol., 12, 267, 10.1002/(SICI)1098-2388(199607/08)12:4<267::AID-SSU6>3.0.CO;2-3 · doi:10.1002/(sici)1098-2388(199607/08)12:4<267::aid-ssu6>3.0.co;2-3
  9. 10.1016/j.canlet.2014.06.007 · doi:10.1016/j.canlet.2014.06.007
  10. Sonmez H, 1995, Tissue fibronectin levels of human prostatic cancer, as a tumor marker, Cancer Biochem Biophys., 15, 107
  11. Ricciardelli C, 1998, Elevated levels of versican but not decorin predict disease progression in early‐stage prostate cancer, Clin Cancer Res., 4, 963
  12. 10.1007/s004180050391 · doi:10.1007/s004180050391
  13. SunT WongN.Transforming growth factor‐β–induced long noncoding RNA promotes liver cancer metastasis via RNA–RNA crosstalk. Hepatology.2015 doi:https://doi.org/10.1002/hep.27599. · doi:10.1002/hep.27599

Cited by

See all 739

Metadata

Authors
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S.
Venue
Clinical and Translational Medicine
Publisher
Wiley
Published
2015-02-26
Volume
4
Issue
1
Pages
6-6
ISSN
2001-1326 (ISSN-L)
OpenAlex
W2137005750
Cited by
739
References
135
FWCI
31.20
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EMT and tumor metastasis. https://app.cochat.ai/papers/10.1186/s40169-015-0048-3
The paper
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015). EMT and tumor metastasis. Clinical and Translational Medicine. https://doi.org/10.1186/s40169-015-0048-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.